MedTrace Logo

Promoting Independent Living in Frail Older Adults by Improving Cognition and Gait Ability and Using Assistive Products

NCT03390478 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2020-01-30

No results posted yet for this study

Summary

A strategy involving 6 partners was planned, targeting the components of education, innovation, and practice-based research with knowledge transfer into clinical practice.The project MIND\&GAIT aims to promote independent living in frail older people through the development of innovative initiatives and systems to improve cognition and gait ability. A structured and integrated Combined Intervention (CI) will be developed, composed by: cognitive stimulation program, an animal-assisted therapy program, a physical activity program. Moreover, an auto-blocking mechanism for rolling walkers will be developed and implemented in this study. The results of the study and all the material that was used, will be disseminated in a web platform.

Conditions

Interventions

OTHER

Combined Intervention Group

Experimental: Combined Intervention Program is composed by a Cognitive Stimulation Program (CSP), a Physical Activity Program (PAP) and Animal Assisted Therapy (AAT). During the PAP participants that use rolling-walkers, will do PAP using the Auto-Blocking kit mechanism for rolling walkers (ABMRW).

Sponsors & Collaborators

  • Instituto Politécnico de Coimbra

    collaborator UNKNOWN

  • Instituto Politécnico de Leiria

    collaborator OTHER

  • Polytechnic University of Santarém

    collaborator OTHER

  • Escola Superior de Enfermagem de Coimbra

    lead OTHER

Principal Investigators

  • João Apóstolo, Aggregation · Nursing School of Coimbra (ESEnfC)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-23
Primary Completion
2018-05-23
Completion
2018-10-22

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03390478 on ClinicalTrials.gov